Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study to Test How BI 3034701 is Taken up and Processed by the Body in Healthy Men With Normal Weight or Overweight
Sponsor: Boehringer Ingelheim
Summary
The main objectives of this trial are: To assess the mass balance (total recovery of \[14C\]-radioactivity) in urine, faeces, and expired air after a single subcutaneous dose of BI 3034701 (C-14) in healthy male trial participants.
Official title: A Phase I, Open-label, Single-dose, Single-arm Trial to Investigate Metabolism and Pharmacokinetics of BI 3034701 (C-14) Administered to (Otherwise) Healthy Male Volunteers With Normal Body Weight or Overweight
Key Details
Gender
MALE
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
8
Start Date
2026-07-29
Completion Date
2026-10-14
Last Updated
2026-07-16
Healthy Volunteers
Yes
Conditions
Interventions
BI 3034701 (C-14)
BI 3034701 mixed with \[C-14\]BI 3034701